Control of onchocerciasis.
暂无分享,去创建一个
[1] P. Ngoumou,et al. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. , 1994, Annals of tropical medicine and parasitology.
[2] B. Benton. Economic impact of onchocerciasis control through the African Programme for Onchocerciasis Control: an overview. , 1998, Annals of tropical medicine and parasitology.
[3] T. Marshall,et al. Studies on onchocerciasis in the United Cameroon Republic. III. A four year follow-up of 6 rain-forest and 6 Sudan-savanna villages. , 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[4] B. Boatin,et al. Diagnostics in onchocerciasis: future challenges. , 1998, Annals of tropical medicine and parasitology.
[5] B. Greene,et al. The status of ivermectin in the treatment of human onchocerciasis. , 1989, The American journal of tropical medicine and hygiene.
[6] H. Gilles,et al. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. , 1985, Annals of tropical medicine and parasitology.
[7] M. Boussinesq,et al. Lutte contre l'onchocercose par ivermectine: résultats d'une campagne de masse au Nord-Cameroun. , 1991 .
[8] M. Grillet,et al. Onchocerciasis hyperendemic in the Unturán mountains: an extension of the endemic region in southern Venezuela. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[9] A. Walker,et al. The maintenance and survival of Theileria annulata in colonies of Hyalomma anatolicum anatolicum. , 1985, Annals of tropical medicine and parasitology.
[10] D. W. Gibson,et al. A diagnostic "patch test" for onchocerciasis using topical diethylcarbamazine. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[11] Adenike Abiose,et al. Onchocerciasis control strategies , 2000, The Lancet.
[12] A. Hoerauf,et al. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis , 2000, The Lancet.
[13] A. Hoerauf,et al. Wolbachia bacterial endosymbionts of filarial nematodes. , 2005, Advances in parasitology.
[14] A. Shelley. Vector aspects of the epidemiology of onchocerciasis in Latin America. , 1988, Annual review of entomology.
[15] J. Habbema,et al. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. , 1995, The Journal of infectious diseases.
[16] B. Benton. Economic impact of onchocerciasis through the African Programme Onchocerciasis Control: control for an overview , 1998 .
[17] R. Baker,et al. Ocular onchocerciasis and intensity of infection in the community. III. West African rainforest foci of the vector Simulium sanctipauli. , 1990, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[18] R. Crosskey. The Natural History of Blackflies , 1990 .
[19] T. Nutman,et al. A universally applicable diagnostic approach to filarial and other infections. , 1994, Parasitology today.
[20] R. Baker,et al. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus. , 1989, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[21] Valérie Obsomer,et al. Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control , 2004, Filaria journal.
[22] S. Lewallen,et al. Blindness in Africa: present situation and future needs , 2001, The British journal of ophthalmology.
[23] S. Graham,et al. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments , 2000, Parasitology.
[24] Tabbarra Kf. Book review: Onchocerciasis and its control, WHO technical report series no. 852, report of WHO expert committee on onchocerciasis control. , 1996 .
[25] T. Nutman,et al. A rapid-format antibody card test for diagnosis of onchocerciasis. , 2000, The Journal of infectious diseases.
[26] D. Molyneux,et al. Patterns of epidemiology and control of onchocerciasis in West Africa , 1997, Journal of Helminthology.
[27] F. Richards,et al. In rural Ugandan communities the traditional kinship/clan system is vital to the success and sustainment of the African Programme for Onchocerciasis Control , 2000, Annals of tropical medicine and parasitology.
[28] R. Murphy,et al. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. , 1985, The New England journal of medicine.
[29] A. Hoerauf,et al. Wolbachia bacteria of filarial nematodes. , 1999, Parasitology today.
[30] A D Négrel,et al. Global data on blindness. , 1995, Bulletin of the World Health Organization.
[31] E. Cupp,et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. , 1992, The American journal of tropical medicine and hygiene.
[32] J. Habbema,et al. Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa , 2003, Filaria journal.
[33] J. Habbema,et al. The risk and dynamics of onchocerciasis recrudescence after cessation of vector control. , 1991, Bulletin of the World Health Organization.
[34] J. Tielsch,et al. Impact of ivermectin on illness and disability associated with onchocerciasis , 2004, Tropical medicine & international health : TM & IH.
[35] D. Boakye,et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.
[36] D. Taylor,et al. Effects of repeated doses of ivermectin on ocular onchocerciasis: community-based trial in Sierra Leone , 1991, The Lancet.
[37] M. Heisler,et al. The Onchocerciasis Elimination Program for the Americas: a history of partnership. , 1998, Revista panamericana de salud publica = Pan American journal of public health.
[38] E. S. Alley,et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. , 1989, Bulletin of the World Health Organization.
[39] E. Miri. Problems and perspectives onchocerciasis control programme: a case study from Plateau state, Nigeria of managing an , 1998 .
[40] G. Burnham,et al. Economic evaluation of Mectizan distribution , 2004, Tropical medicine & international health : TM & IH.
[41] E. Emukah,et al. Missed treatment opportunities, for pregnant and breast-feeding women, in onchocerciasis mass-treatment programmes in south–eastern Nigeria , 2004, Annals of tropical medicine and parasitology.
[42] M. Muehlen,et al. Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. , 2004, Bulletin of the World Health Organization.
[43] A. Abiose. Onchocercal eye disease and the impact of Mectizan treatment. , 1998, Annals of tropical medicine and parasitology.
[44] M. Neira,et al. Final report of the Conference on the eradicability of Onchocerciasis , 2003, Filaria journal.
[45] U. Amazigo. Detrimental effects of onchocerciasis on marriage age and breast-feeding. , 1994, Tropical and geographical medicine.
[46] H. Newland,et al. The use of diethylcarbamazine cream in the diagnosis of onchocerciasis. , 1987, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ).
[47] V. Tanya,et al. Repeated high doses of avermectins cause prolonged sterilisation, but do not kill, Onchocerca ochengi adult worms in African cattle , 2005, Filaria journal.
[48] A. Abiose. Onchocercal eye disease Mectizan treatment and the impact of , 1998 .
[49] N. Opoku,et al. The chemotherapy of onchocerciasis XVIII. Aspects of treatment with suramin. , 1995, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[50] E. Pearlman,et al. Immune mechanisms in Onchocerca volvulus‐mediated corneal disease (river blindness) , 2000, Parasite immunology.
[51] L. Stephenson,et al. Metrifonate or praziquantel treatment improves physical fitness and appetite of Kenyan schoolboys with Schistosoma haematobium and hookworm infections. , 1990, The American journal of tropical medicine and hygiene.
[52] F. Richards,et al. Whither onchocerciasis control in Africa? , 2005, The American journal of tropical medicine and hygiene.
[53] A. Hoerauf,et al. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment , 2001, The Lancet.
[54] B. Duke. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms , 2004, Parasitology.
[55] J. Heukelbach,et al. Ectoparasites—the underestimated realm , 2004, The Lancet.
[56] W. Brieger,et al. The challenges of community-directed treatment with ivermectin (CDTI) within the African Programme for Onchocerciasis Control (APOC) , 2002, Annals of tropical medicine and parasitology.
[57] B. Thylefors. Eliminating onchocerciasis as a public health problem , 2004, Tropical medicine & international health : TM & IH.
[58] A. Hoerauf,et al. The Role of Endosymbiotic Wolbachia Bacteria in the Pathogenesis of River Blindness , 2002, Science.
[59] T. Burch,et al. Pathologic effects of suramin, hetrazan and arsenamide on adult Onchocerca volvulus. , 1949, Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau.
[60] D. Etya’ale,et al. Ten years of NGDO action against river blindness. , 2002, Trends in parasitology.
[61] P. Guillet,et al. Criteria for the selection of larvicides by the Onchocerciasis Control Programme in west Africa. , 1993, Annals of tropical medicine and parasitology.
[62] T. Nutman,et al. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. , 1994, The Journal of infectious diseases.
[63] F. Richards,et al. Control of onchocerciasis today: status and challenges. , 2001, Trends in parasitology.
[64] H. Gilles,et al. The chemotherapy of onchocerciasis iii. A comparative study of diethylcarbamazide (DEC) and metrifonate. , 1980, Annals of tropical medicine and parasitology.
[65] E. Cupp,et al. Comparison of the effects of a single dose and of four six-monthly doses of ivermectin on adult Onchocerca volvulus. , 1991, The American journal of tropical medicine and hygiene.
[66] E. Cupp,et al. The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus. , 1989, The American journal of tropical medicine and hygiene.
[67] D. Wirth,et al. Cloning and characterization of an Onchocerca volvulus specific DNA sequence. , 1989, Molecular and biochemical parasitology.
[68] Ogbuagu,et al. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial , 1998, Tropical medicine & international health : TM & IH.
[69] M. Boussinesq,et al. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. , 1998, The American journal of tropical medicine and hygiene.
[70] M. Hagan. Onchocercal dermatitis: clinical impact. , 1998, Annals of tropical medicine and parasitology.
[71] J. Habbema,et al. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination , 2001, BMC public health.
[72] B. Benton. Cost-Benefit Analysis of the Onchocerciasis Control Program (OCP) , 1995 .
[73] S. Cousens,et al. Ivermectin dose assessment without weighing scales. , 1993, Bulletin of the World Health Organization.
[74] J. B. Davies. Sixty years of onchocerciasis vector control: a chronological summary with comments on eradication, reinvasion, and insecticide resistance. , 1994, Annual review of entomology.
[75] O. Onwujekwe,et al. Community-directed treatment with ivermectin in two Nigerian communities: an analysis of first year start-up processes, costs and consequences. , 2002, Health policy.
[76] Mark J. Taylor,et al. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon , 2005, Filaria journal.
[77] D. Molyneux. Onchocerciasis control in West Africa: Current status and future of the onchocerciasis control programme , 1995 .
[78] E. Cupp,et al. Programmatic goals and approaches to onchocerciasis , 2000, The Lancet.
[79] D. Blacklock. The Development of Onchocerca volvulus in Simulium damnosum. , 1926 .
[80] C. Mackenzie,et al. Medical achievements under civil war conditions , 1999, The Lancet.
[81] M. Boussinesq,et al. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection , 1997, The Lancet.
[82] M. Thomson,et al. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa , 2000, The Lancet.
[83] F. Richards,et al. A longitudinal study of impact of repeated mass ivermectin treatment on clinical manifestations of onchocerciasis in Imo State, Nigeria. , 2004, The American journal of tropical medicine and hygiene.
[84] J D Habbema,et al. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. , 1990, Computer methods and programs in biomedicine.
[85] P. Cooper,et al. Successful control of onchocerciasis with community‐based ivermectin distribution in the Rio Santiago focus in Ecuador , 1997, Tropical medicine & international health : TM & IH.
[86] B. Thylefors,et al. [Treatment of onchocerciasis in hyperendemic communities in West Africa with small, gradually increasing doses of suramin. 1. Parasitological results and ophthalmological surveillance in a region where transmission has not been interrupted]. , 1980, Bulletin of the World Health Organization.
[87] R. Eversole,et al. The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. , 2004, The American journal of tropical medicine and hygiene.
[88] J. Habbema,et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa? , 2002, Bulletin of the World Health Organization.
[89] T. Mebrahtu,et al. Review: The delivery of ivermectin (Mectizan®) , 2004 .
[90] T. Unnasch,et al. Pool screen polymerase chain reaction for estimating the prevalence of Onchocerca volvulus infection in Simulium damnosum sensu lato: results of a field trial in an area subject to successful vector control. , 1999, The American journal of tropical medicine and hygiene.
[91] E. Pearlman,et al. Pathogenesis of Onchocercal Keratitis (River Blindness) , 1999, Clinical Microbiology Reviews.
[92] K. R. Brown,et al. Ivermectin--clinical trials and treatment schedules in onchocerciasis. , 1990, Acta Leidensia.
[93] E. Cupp,et al. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following biannual treatments in five Guatemalan communities. , 1992, The American journal of tropical medicine and hygiene.
[94] T R Unnasch,et al. Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. , 1995, The Journal of infectious diseases.
[95] O. Kale. Onchocerciasis: the burden of disease , 1998 .
[96] J. B. Davies. Description of a computer model of forest onchocerciasis transmission and its application to field scenarios of vector control and chemotherapy. , 1993, Annals of tropical medicine and parasitology.
[97] J D Habbema,et al. Epidemiological modelling for onchocerciasis control. , 1992, Parasitology today.